XAF1 and neoplasm: Among 12 recurrent patients, 10 patients displayed negative-to-positive transition in XAF1 methylation status in their sera, the other two showed always positive for XAF1 methylation, suggesting that monitoring of XAF1 methylation in serum may be a good marker for predicting tumor recurrence (Table 3).